# Oricula Therapeutics LLC: Form D filings

Oricula Therapeutics LLC, a biotechnology company in Seattle, WA, filed 5 Form D notices with the SEC between 2013 and 2020. The latest, on April 22, 2020, reports an offering of $500,000 with nothing sold yet.

Find out what Oricula Therapeutics LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Oricula%20Therapeutics%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Oricula%20Therapeutics%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Foricula-therapeutics-llc-1590934)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Oricula%20Therapeutics%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Oricula%20Therapeutics%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Foricula-therapeutics-llc-1590934)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Washington](https://specstream.ai/data/form-d/state/washington): 1,095 rows, by operating companies, filed since November 1, 2024, $54.75, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/washington
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 474 39TH AVENUE EAST, Seattle, WA, 98112
- Phone: (206) 322-7526
- Industry: Biotechnology
- Entity type: Limited Liability Company
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1590934

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 22, 2020 | New notice | $500,000 | $0 | $500,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1590934/000159093420000001/0001590934-20-000001-index.htm) |
| Dec 22, 2017 | New notice | $2,500,000 | $30,000 | $2,470,000 | 1 | Dec 14, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1590934/000155911817000003/0001559118-17-000003-index.htm) |
| May 15, 2017 | New notice | $400,000 | $25,000 | $375,000 | 1 | May 12, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1590934/000159093417000001/0001590934-17-000001-index.htm) |
| Jan 21, 2015 | New notice | $450,000 | $45,000 | $405,000 | 1 | Jan 16, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1590934/000159093415000001/0001590934-15-000001-index.htm) |
| Nov 4, 2013 | New notice | $150,000 | $75,000 | $75,000 | 4 | Oct 15, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1590934/000159093413000001/0001590934-13-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Ed Rubel | Director, Promoter |  |
| Vince Groppi | Director, Promoter |  |
| Malcolm Gleser | Executive Officer, Director, Promoter |  |

## Other biotechnology companies in Washington that filed recently

- [Key Proteo, Inc.](https://specstream.ai/data/form-d/company/key-proteo-inc-1977784) $2.3 million · Oct 23, 2026
- [Inmedix, Inc.](https://specstream.ai/data/form-d/company/inmedix-inc-1851853) $4 million · Oct 22, 2026
- [Q-Immune, Inc.](https://specstream.ai/data/form-d/company/q-immune-inc-2155816) $25,000 · Sep 28, 2026
- [Hexamer Therapeutics, Inc](https://specstream.ai/data/form-d/company/hexamer-therapeutics-inc-1797915) $500,000 · Sep 15, 2026
- [MalarVx, Inc.](https://specstream.ai/data/form-d/company/malarvx-inc-1559688) $125,000 · Aug 25, 2026
- [Strella Biotechnology, Inc.](https://specstream.ai/data/form-d/company/strella-biotechnology-inc-1810011) $1.8 million · Aug 14, 2026

[Every Form D from the week of Apr 20, 2020](https://specstream.ai/data/form-d/week/2020-04-20) · [All recent filings in Washington](https://specstream.ai/data/form-d/state/washington) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Oricula Therapeutics LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).